ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

NTV Northern 2 Vct Plc

54.50
0.00 (0.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Northern 2 Vct Plc LSE:NTV London Ordinary Share GB0005356430 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 54.50 53.00 56.00 54.50 54.50 54.50 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Investors, Nec -2.96M -3.46M -0.0177 -30.79 106.47M

Northern 2 VCT PLC Net Asset Value

17/07/2018 10:30am

UK Regulatory


 
TIDMNTV 
 
 
   17 JULY 2018 
 
   NORTHERN 2 VCT PLC 
 
   UNAUDITED NET ASSET VALUE AS AT 30 JUNE 2018 
 
   Northern 2 VCT PLC ("the Company") is a Venture Capital Trust ("VCT") 
launched in 1999 and managed by NVM Private Equity LLP.  The Company's 
objective is to provide high long-term tax-free returns to investors 
through a combination of dividend yield and capital growth, by investing 
in a portfolio of investments mainly comprising unquoted venture capital 
holdings.  In order to maintain approval by HM Revenue & Customs as a 
VCT, the Company is required to comply on a continuing basis with the 
provisions of Section 274 of the Income Tax Act 2007. 
 
   The unaudited net asset value per ordinary share as at 30 June 2018 was 
66.7 pence (31 March 2018 (audited) 66.9 pence).  The net asset value is 
stated before deducting the final dividend of 3.5 pence per share in 
respect of the year ended 31 March 2018, which will be paid to eligible 
shareholders on 20 July 2018. 
 
   For the purposes of calculating the net asset value per share, quoted 
investments are carried at bid price as at 30 June 2018 and unquoted 
investments are carried at fair value as at 30 June 2018 as determined 
by the directors. 
 
   During the three months ended 30 June 2018 the following new venture 
capital investments were completed: 
 
 
 
 
                                                                                 Amount 
                                                                                 invested 
 Name of company    Business activity                                             GBP000 
-----------------  -----------------------------------------------------------  --------- 
Ablatus 
 Therapeutics      Development of medical devices to treat cancerous 
 Limited            tumours                                                           322 
                   Software solution to automate the preparation of documents 
Clarilis Limited    for the legal sector                                            1,012 
Newcells Biotech   Development of innovative efficacy and toxicity testing 
 Limited            solutions for the drug discovery sector                           484 
 
 
   The number of ordinary shares in issue at 30 June 2018 was 130,089,490. 
During the three months ended 30 June 2018 there were no movements in 
the number of shares in issue. 
 
   Enquiries: 
 
   Simon John/James Bryce, NVM Private Equity LLP -- 0191 244 6000 
 
   Website:  www.nvm.co.uk 
 
   Neither the contents of the NVM Private Equity LLP website nor the 
contents of any website accessible from hyperlinks on the NVM Private 
Equity LLP website (or any other website) is incorporated into, or forms 
part of, this announcement. 
 
 
 
 

(END) Dow Jones Newswires

July 17, 2018 05:30 ET (09:30 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.

1 Year Northern 2 Vct Chart

1 Year Northern 2 Vct Chart

1 Month Northern 2 Vct Chart

1 Month Northern 2 Vct Chart

Your Recent History

Delayed Upgrade Clock